MINAPHARM Pharmaceuticals (EGX:MIPH)
Egypt · Delayed Price · Currency is EGP 331.12
0.00 (0.00%)
At close: Feb 2, 2026
MINAPHARM Pharmaceuticals Cash Flow Statement
Financials in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 140.9 | 157.07 | -31.99 | 612.66 | 466.41 | 300.78 |
Depreciation & Amortization | 348.86 | 284.71 | 192.23 | 132.86 | 85.99 | 82.9 |
Loss (Gain) From Sale of Assets | 5.36 | 5.67 | 0.17 | - | -0.46 | - |
Provision & Write-off of Bad Debts | 37.84 | 39.15 | 12.64 | -2.67 | -8.91 | 7.29 |
Other Operating Activities | 182.74 | 159.72 | -88.92 | 81.64 | 90.93 | 63.48 |
Change in Accounts Receivable | -162.44 | -271.35 | -147.28 | -168.51 | -22.41 | -81.04 |
Change in Inventory | -68.91 | -180.96 | -226.43 | -171.08 | -83.29 | -101.36 |
Change in Accounts Payable | -107.07 | 265.8 | 39.82 | 265.15 | -91.57 | 208.89 |
Change in Other Net Operating Assets | -0.59 | -238.28 | 352.1 | -188.28 | -229.4 | -43.82 |
Operating Cash Flow | 376.68 | 221.51 | 102.34 | 561.77 | 207.28 | 437.13 |
Operating Cash Flow Growth | 135.51% | 116.44% | -81.78% | 171.03% | -52.58% | 112.40% |
Capital Expenditures | -813.18 | -918.96 | -1,395 | -1,160 | -387.87 | -150.29 |
Sale of Property, Plant & Equipment | - | - | 0.17 | - | 0.76 | 0.11 |
Sale (Purchase) of Intangibles | -3.86 | -0.09 | -10.65 | -2.03 | -1.82 | -3.13 |
Other Investing Activities | 31.45 | 45.26 | 0 | 0 | -0.01 | 5.77 |
Investing Cash Flow | -785.6 | -573.79 | -1,405 | -1,162 | -388.94 | -147.55 |
Short-Term Debt Issued | - | 2,496 | 1,020 | 494.8 | - | - |
Long-Term Debt Issued | - | 1,380 | 459.34 | 636.62 | 425.73 | 119.24 |
Total Debt Issued | 5,494 | 3,876 | 1,479 | 1,131 | 425.73 | 119.24 |
Short-Term Debt Repaid | - | -2,227 | - | - | -205.3 | -49.74 |
Long-Term Debt Repaid | - | -292.72 | -128.71 | -12.15 | -11.86 | - |
Total Debt Repaid | -5,717 | -2,520 | -128.71 | -12.15 | -217.16 | -49.74 |
Net Debt Issued (Repaid) | -222.78 | 1,356 | 1,350 | 1,119 | 208.57 | 69.5 |
Repurchase of Common Stock | - | - | - | -69.63 | - | - |
Common Dividends Paid | -52.08 | -40.16 | -53.87 | -57.79 | -49.8 | -88.23 |
Other Financing Activities | -6.87 | - | -0.08 | 2.31 | -3.2 | -8 |
Financing Cash Flow | 1,178 | 1,316 | 1,296 | 994.16 | 155.57 | -26.73 |
Foreign Exchange Rate Adjustments | -221.82 | 5.49 | 230.86 | 317.88 | -13.97 | -10.38 |
Miscellaneous Cash Flow Adjustments | - | - | - | - | -1.5 | - |
Net Cash Flow | 547.34 | 969.43 | 224.34 | 711.56 | -41.56 | 252.48 |
Free Cash Flow | -436.5 | -697.45 | -1,292 | -598.45 | -180.6 | 286.84 |
Free Cash Flow Margin | -6.30% | -12.31% | -33.21% | -16.53% | -6.01% | 12.15% |
Free Cash Flow Per Share | -39.45 | -63.04 | -116.81 | -52.16 | -14.69 | 23.33 |
Cash Interest Paid | 747.42 | 593.68 | 254.46 | 62.17 | 48.84 | 69.3 |
Cash Income Tax Paid | 76.77 | 26.07 | 132.95 | 182.39 | 154.77 | 63.23 |
Levered Free Cash Flow | -412.98 | -422.87 | -1,289 | -622.61 | -139.42 | 277.3 |
Unlevered Free Cash Flow | 54.16 | -51.82 | -1,130 | -583.75 | -108.9 | 320.61 |
Change in Working Capital | -339.01 | -424.79 | 18.21 | -262.72 | -426.67 | -17.33 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.